Meristem Family Wealth, LLC Amgen Inc Transaction History

Meristem Family Wealth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $445,104 - $501,996	-1,983 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $378,240 - $418,433	-1,725 Reduced 46.52%	1,983 $480,000
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $139,613 - $159,775	-702 Reduced 15.92%	3,708 $834,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $437,700 - $512,819	2,062 Added 87.82%	4,410 $938,000
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $291,975 - $323,925	1,250 Added 113.84%	2,348 $572,000
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $19,971 - $23,274	90 Added 8.93%	1,098 $273,000
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $1,640 - $2,175	9 Added 0.9%	1,008 $204,000
Q4 2019 Jan 31, 2020	BUY	$189.21 - $243.2 $189,020 - $242,956	999 New	999 $241,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Meristem Family Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Meristem Family Wealth, LLC with notifications on news.